SOLV vs. DHR: Which Stock Is the Better Value Option?
Investors interested in Medical Services stocks are likely familiar with Solventum ( SOLV Quick QuoteSOLV - ) and Danaher ( DHR Quick QuoteDHR - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon
If you have decades of investing runway left, consider these two top healthcare stocks.
SOLV or DHR: Which Is the Better Value Stock Right Now?
SOLV vs. DHR: Which Stock Is the Better Value Option?
Global Microfluidics Market to Surpass USD 32.67 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- The global microfluidics market, valued at US$21.36 billion in 2023, stood at US$22.43 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$32.67 billion by the ...
Envista ( NVST ) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is the Market Bullish or Bearish on Danaher Corp? - Danaher ( NYSE:DHR )
Danaher Corp's ( NYSE:DHR ) short interest as a percent of float has fallen 5.93% since its last report. According to exchange reported data, there are now 7.98 million shares sold short, which is 1.27% of all regular shares that are available for trading.
Unlocking Danaher ( DHR ) International Revenues: Trends, Surprises, and Prospects
Explore Danaher's (DHR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher ( NYSE:DHR )
Danaher ( NYSE:DHR ) has outperformed the market over the past 10 years by 1.03% on an annualized basis producing an average annual return of 13.48%. Currently, Danaher has a market capitalization of $154.05 billion.
These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings - Danaher ( NYSE:DHR )
Danaher Corporation ( NYSE:DHR ) reported better-than-expected third-quarter financial results on Tuesday. Danaher announced third-quarter adjusted earnings of $1.89 per share, which beat the analyst consensus estimate of $1.72 per share by 9.82%.
Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher Scientific Inc. ( NYSE:TMO ) on Wednesday reported third-quarter 2025 adjusted earnings of $5.79 per share, beating the street view of $5.49. Quarterly sales of $11.12 billion increased 5% year-over-year, beating the analyst consensus estimate of $10.91 billion.
Company News for Oct 22, 2025
Companies in The News Are: KO, ...
Danaher Reports Strong Q3 Earnings, Shares Move Higher - Danaher ( NYSE:DHR )
Danaher Corporation ( NYSE:DHR ) shares are rising Tuesday after the company reported better-than-expected third-quarter financial results. DHR is charging ahead with explosive momentum. View the charts here.
Here's Why Shares in Danaher Got Boosted Higher Today
The company's third-quarter earnings pleased investors.
Danaher Q3 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
DHR Q3 earnings and sales beat estimates, driven by solid segment growth and stronger operating margins.
Gold Sinks 5% On Worst Day In 5 Years, Dow Jones Hits Record Highs - VanEck Gold Miners ETF ( ARCA:GDX )
Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, while optimism across earnings kept industrial stocks powering higher and pushed the Dow Jones to fresh record highs.
General Motors Posts Upbeat Q3 Results, Joins Halliburton, Danaher, Crown Holdings And Other Big Stocks Moving Higher On Tuesday - Beyond Meat ( NASDAQ:BYND ) , Crown Holdings ( NYSE:CCK )
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Tuesday. Shares of General Motors Company ( NYSE:GM ) rose sharply during Tuesday's session after the company reported better-than-expected third-quarter financial results and raised FY25 adjusted EPS outlook.
Danaher ( DHR ) Q3 Earnings and Revenues Beat Estimates
Danaher (DHR) delivered earnings and revenue surprises of +10.53% and +0.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR - Danaher ( NYSE:DHR )
NEW YORK, Oct. 20, 2025 ( GLOBE NEWSWIRE ) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation ( NYSE:DHR ) .
LH vs. DHR: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Labcorp Holdings ( LH Quick QuoteLH - ) and Danaher ( DHR Quick QuoteDHR - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?
DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.
Wall Street's Insights Into Key Metrics Ahead of Danaher ( DHR ) Q3 Earnings
Besides Wall Street's top-and-bottom-line estimates for Danaher (DHR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Medpace ( MEDP ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Corning Rises 62.8% in Three Months: Is the Stock Worth Buying?
GLW's 62.8% stock surge, AI-driven fiber demand, and expanding partnerships signal strong growth momentum and attractive valuation.
Danaher ( DHR ) Reports Next Week: Wall Street Expects Earnings Growth
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Top Healthcare Stocks to Buy in October
Healthcare stocks haven't been very popular this year. It could be a great time to buy some of the industry's leaders.
Looking Into Danaher Corp's Recent Short Interest - Danaher ( NYSE:DHR )
Danaher Corp's ( NYSE:DHR ) short interest as a percent of float has fallen 9.4% since its last report. According to exchange reported data, there are now 8.60 million shares sold short, which is 1.35% of all regular shares that are available for trading.
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday - BOK Financial ( NASDAQ:BOKF ) , Danaher ( NYSE:DHR )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Securities raised Flex Ltd. ( NYSE:FLEX ) price target from $58 to $65.
This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - FedEx ( NYSE:FDX ) , Danaher ( NYSE:DHR )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Cell Culture Market is expected to generate a revenue of USD 93.49 Billion by 2032, Globally, at 14.23% CAGR: Verified Market Research®
Lewes, Delaware, Oct. 06, 2025 ( GLOBE NEWSWIRE ) -- The Global Cell Culture Market Size is projected to grow at a CAGR of 14.23% from 2026 to 2032, according to a new report published by Verified Market Research®.
BLCO vs. DHR: Which Stock Should Value Investors Buy Now?
BLCO vs. DHR: Which Stock Is the Better Value Option?
Here's Why Envista ( NVST ) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
A Look Into Danaher Inc's Price Over Earnings - Danaher ( NYSE:DHR )
In the current market session, Danaher Inc. ( NYSE: DHR ) price is at $183.36, after a 1.05% spike. However, over the past month, the stock fell by 10.91%, and in the past year, by 34.05%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is ...
Can Danaher's Diagnostics Unit Sustain Growth Amid Lower Sales in China?
DHR's Diagnostics unit posts steady Q2 growth, led by Beckman Coulter demand, while China headwinds weigh on results.
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation ...
DANAHER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR - Danaher ( NYSE:DHR )
NEW YORK and NEW ORLEANS, Sept. 17, 2025 ( GLOBE NEWSWIRE ) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ( "KSF" ) , announces that KSF has commenced an investigation into Danaher Corporation DHR.
Danaher's Life Sciences Segment Shrinks: What's the Path Forward?
DHR's Life Sciences unit faces revenue declines from weak demand, but new products and biotech advances offer growth potential.
myGwork's WorkFair 2025 Returns on 5 November with Global Job Opportunities for LGBTQ+ Students, Graduates, and Allies
LONDON, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- myGwork, the leading global inclusive talent platform, is proud to announce the return of WorkFair on 5 November 2025. Powered by VFairs, this global virtual career event connects LGBTQ+ students, graduates, and allies with inclusive employers ...
Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?
HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound.
Why Envista ( NVST ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?
DHR's Biotechnology unit grows 6% in Q2, driven by bioprocessing, despite weakness in research equipment demand.
Mueller Water Products Appoints Darin Harvey as Senior Vice President of Operations and Supply Chain - Mueller Water Products ( NYSE:MWA ) , Advanced Drainage Systems ( NYSE:WMS )
ATLANTA, Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- Mueller Water Products, Inc. MWA, a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America, announced that it has named Darin Harvey as its Senior Vice President of ...
Mueller Water Products Appoints Darin Harvey as Senior Vice President of Operations and Supply Chain
ATLANTA, Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- Mueller Water Products, Inc. ( NYSE: MWA ) , a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America, announced that it has named Darin Harvey as its Senior Vice ...
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR - Danaher ( NYSE:DHR )
NEW YORK, Sept. 07, 2025 ( GLOBE NEWSWIRE ) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation DHR.
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point - Bio-Techne ( NASDAQ:TECH )
RBC Capital upgraded Bio-Techne to Outperform and lifted its price target from $61 to $73. Bio-Techne shares are down 26% over the past year and 25% year-to-date. Get Discounted Real-Time Trade Alerts For a Volatile Market ( Labor Day Special )
Danaher Gains From Business Strength Amid Persisting Headwinds
DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.
Why Is Teladoc ( TDOC ) Up 4.6% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How Do Investors Really Feel About Danaher? - Danaher ( NYSE:DHR )
Danaher's DHR short percent of float has risen 12.03% since its last report. The company recently reported that it has 9.47 million shares sold short, which is 1.49% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.73 days to cover their ...
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Dan Loeb's Third Point Bets Big On AI, Tech With $442 Million Nvidia Stake-Exits Energy, Steel In Q2 Portfolio Overhaul - NVIDIA ( NASDAQ:NVDA )
Third Point LLC, the hedge fund led by billionaire investor Dan Loeb, has significantly reshaped its portfolio in the second quarter of 2025, doubling down on artificial intelligence and technology with a massive $442.37 million stake in Nvidia Corp., according to its latest 13F filing.
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher ( NYSE:DHR )
Danaher DHR has outperformed the market over the past 10 years by 1.07% on an annualized basis producing an average annual return of 13.56%. Currently, Danaher has a market capitalization of $151.72 billion.
